Sentral Mitra Informatika Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sentral Mitra Informatika Tbk. trades at Rp98 (market cap 69.43B, 724.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.4× Sentral Mitra Informatika Tbk.'s market cap, and Sentral Mitra Informatika Tbk. is more actively traded (724.7K versus 96.7K). Which is the better fit depends on your goals.
| LUCK | OBAT | |
|---|---|---|
Market Cap | 69.43B | 167.37B |
Volume | 724.7K | 96.7K |
Lot | 7.25K | 967 |
Turnover | 70.51M | 23.82M |
Average Price | 97.3 | 246.34 |
Value | 70.51M | 23.82M |
Indicative Equilibrium Price | 98 | 248 |
Indicative Equilibrium Volume | 163 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sentral Mitra Informatika Tbk (the Company), was established in the Republic of Indonesia under the framework of the Domestic Capital Investment Law No. 6 year 1968 based on notarial Deed No. 11 dated November 14, 2008 of Henny Hendrawati Putradjaja, S.H., Notary in Jakarta.
Read more on LUCK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →